Exosens
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultraviolet, short, medium, and long wave infrared, visible - near infrared, and mid-wave infrared cameras, as well as enhanced vi… Read more
Exosens (H8Y) - Total Assets
Latest total assets as of June 2025: €867.32 Million EUR
Based on the latest financial reports, Exosens (H8Y) holds total assets worth €867.32 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Exosens - Total Assets Trend (2021–2024)
This chart illustrates how Exosens’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Exosens - Asset Composition Analysis
Current Asset Composition (December 2024)
Exosens's total assets of €867.32 Million consist of 38.5% current assets and 61.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 14.4% |
| Accounts Receivable | €71.00 Million | 8.7% |
| Inventory | €93.00 Million | 11.4% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €204.90 Million | 25.1% |
| Goodwill | €189.50 Million | 23.2% |
Asset Composition Trend (2021–2024)
This chart illustrates how Exosens's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Exosens's current assets represent 38.5% of total assets in 2024, an increase from 24.5% in 2021.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2024, up from 3.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, a decrease from 63.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 25.1% of total assets.
Exosens Competitors by Total Assets
Key competitors of Exosens based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
YM Tech Co. Ltd.
KQ:273640
|
Korea | ₩61.47 Billion |
|
T-Conn Precision Corporation
TWO:6833
|
Taiwan | NT$1.20 Billion |
|
Supercomnet Technologies Bhd
KLSE:0001
|
Malaysia | RM454.76 Million |
|
XJ Electric Co Ltd
SHE:000400
|
China | CN¥26.30 Billion |
|
Guangdong Macro Co Ltd
SHE:000533
|
China | CN¥2.88 Billion |
|
Shandong Sacred Sun Power Sources Co Ltd
SHE:002580
|
China | CN¥4.04 Billion |
|
Shandong Xinneng Taishan Power Generation Co Ltd
SHE:000720
|
China | CN¥5.21 Billion |
|
Huagong Tech Co Ltd
SHE:000988
|
China | CN¥21.08 Billion |
Exosens - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Exosens generates 0.48x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Exosens generates $ 3.76 in net profit.
Exosens - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.51 | 2.83 | - |
| Quick Ratio | 1.67 | 1.98 | - |
| Cash Ratio | 0.00 | 0.00 | - |
| Working Capital | €188.99 Million | € 204.11 Million | - |
Exosens - Advanced Valuation Insights
This section examines the relationship between Exosens's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 2.22 |
| Asset Growth Rate (YoY) | 24.5% |
| Total Assets | €817.00 Million |
| Market Capitalization | $1.82 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Exosens's assets at a significant premium ( 2.22x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Exosens's assets grew by 24.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Exosens (2021–2024)
The table below shows the annual total assets of Exosens from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €817.00 Million | +24.46% |
| 2023-12-31 | €656.41 Million | +24.03% |
| 2022-12-31 | €529.25 Million | +14.93% |
| 2021-12-31 | €460.52 Million | -- |